FDA warning signs assist when GH is authorised; off-label use calls for mighty evidence, cautious monitoring

https://atavi.com/share/xs4mgkz1gle3g

FDA symptoms publication while GH is authorised; off-label use calls for potent evidence, cautious monitoring, and obvious consent discussions.